Micro Emerging Active

SNY positive Phase 3 results for amlitelimab

评分
0.2
动能
▲ 0.0
文章
1
来源
1

摘要

An article belongs to this narrative if it discusses Sanofi's Phase 3 trial results for amlitelimab.

相关文章

Sanofi Reports Positive Phase 3 Results For Amlitelimab In Atopic Dermatitis

Nasdaq · 三月 28, 2026
Mixed

来源

Sanofi Reports Positive Phase 3 Results For Amlitelimab In Atopic … Nasdaq

时间线

最后更新 三月 28, 2026